Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Shunji NAKAJIMA"'
Autor:
Tsutomu Yoshihara, Yosuke Oikawa, Takayuki Kato, Takaomi Kessoku, Takashi Kobayashi, Shingo Kato, Noboru Misawa, Keiichi Ashikari, Akiko Fuyuki, Hidenori Ohkubo, Takuma Higurashi, Yoko Tateishi, Yoshiki Tanaka, Shunji Nakajima, Hiroshi Ohno, Koichiro Wada, Atsushi Nakajima
Publikováno v:
Gut Microbes, Vol 11, Iss 5, Pp 1385-1404 (2020)
Background Proton pump inhibitors (PPIs) can alleviate upper gastrointestinal injury but paradoxically exacerbate aspirin (ASA)-induced small intestine injury. In this study, our goal was to simulate this exacerbation by developing an appropriate ani
Externí odkaz:
https://doaj.org/article/501133c54fea4df69cb98f96bd953809
Autor:
Fumie Takewaki, Hanako Nakajima, Daiki Takewaki, Yoshitaka Hashimoto, Saori Majima, Hiroshi Okada, Takafumi Senmaru, Emi Ushigome, Masahide Hamaguchi, Masahiro Yamazaki, Yoshiki Tanaka, Shunji Nakajima, Hiroshi Ohno, Michiaki Fukui
Publikováno v:
Nutrients, Vol 13, Iss 6, p 2107 (2021)
The aim of this research was to reveal the characteristics of gut microbiome altered by acarbose intervention in Japanese patients with type 2 diabetes (T2D) and its possible association with habitual dietary intake. Eighteen patients with T2D were a
Externí odkaz:
https://doaj.org/article/1abbf483943b4d3d9edafbe7681e9341
Autor:
Hanako Nakajima, Fumie Takewaki, Yoshitaka Hashimoto, Shizuo Kajiyama, Saori Majima, Hiroshi Okada, Takafumi Senmaru, Emi Ushigome, Naoko Nakanishi, Masahide Hamaguchi, Masahiro Yamazaki, Yoshiki Tanaka, Yousuke Oikawa, Shunji Nakajima, Hiroshi Ohno, Michiaki Fukui
Publikováno v:
Life, Vol 10, Iss 9, p 195 (2020)
Metformin is reported to affect human gut microbiota; however, the nature of this association in Japanese patients with type 2 diabetes mellitus (T2DM) is unknown. We enrolled 31 patients with T2DM who took metformin for the first time in this study.
Externí odkaz:
https://doaj.org/article/ab40fcab6a3b4b4a90e4822e852d89cf
Autor:
Keisuke OKADA, Daisuke TAKAMI, Yutaka MAKIZAKI, Yoshiki TANAKA, Shunji NAKAJIMA, Hiroshi OHNO, Toru SAGAMI
Publikováno v:
Bioscience of Microbiota, Food and Health.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3da9d5a95c746bf6e20d4f95d063bc22
https://doi.org/10.12938/bmfh.2022-066
https://doi.org/10.12938/bmfh.2022-066
Autor:
Hiroshi Ohno, Yosuke Oikawa, Yoshiki Tanaka, Yoko Tateishi, Takuma Higurashi, Shingo Kato, Tsutomu Yoshihara, Keiichi Ashikari, Hidenori Ohkubo, Shunji Nakajima, Noboru Misawa, Akiko Fuyuki, Takashi Kobayashi, Koichiro Wada, Takaomi Kessoku, Takayuki Kato, Atsushi Nakajima
Publikováno v:
Gut Microbes, Vol 11, Iss 5, Pp 1385-1404 (2020)
Background Proton pump inhibitors (PPIs) can alleviate upper gastrointestinal injury but paradoxically exacerbate aspirin (ASA)-induced small intestine injury. In this study, our goal was to simulate this exacerbation by developing an appropriate ani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466bed54c091a4f971339763b2cfbd2f
https://doi.org/10.1080/19490976.2020.1758290
https://doi.org/10.1080/19490976.2020.1758290
Autor:
Yutaka Makizaki, Shunji Nakajima, Ayako Maeda, Hiroshi Ohno, Saya Tamura, Miyuki Yamamoto, Yoshiki Tanaka
Publikováno v:
Bioscience of Microbiota, Food and Health. 39:145-151
Recent studies of metformin, the first-line drug for type 2 diabetes, have reported the involvement of gut microbiota in the mechanism underlying its antihyperglycemic effect. However, the mechanisms underlying the development of diarrhea and bloatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d290771c794918013b95dd60a0fecf79
https://doi.org/10.12938/bmfh.2019-022
https://doi.org/10.12938/bmfh.2019-022
Autor:
Yosuke Oikawa, Shunji Nakajima, Hideki Yamamura, Yoshiki Tanaka, Hiroshi Ohno, Saya Tamura, Ayako Maeda, Yutaka Makizaki
Publikováno v:
Microbiology and Immunology. 63:481-486
Diarrhea is largely caused by dysbiosis accompanying the hyperproliferation of Escherichia coli (E. coli). While current treatments can resolve the symptoms, they cannot suppress the proliferation of pathogenic bacteria in the intestine. Probiotics h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56ab22b27ac6d183c32e92dd0df1038b
https://doi.org/10.1111/1348-0421.12743
https://doi.org/10.1111/1348-0421.12743
Autor:
Hideki Yamamura, Shunji Nakajima, Yutaka Makizaki, Yoshiki Tanaka, Saya Tamura, Yosuke Oikawa, Ayako Maeda
Publikováno v:
Bioscience of Microbiota, Food and Health
Constipation, a functional disorder of the digestive system, is common in children and adults and may compromise patient quality of life. Because many patients are not satisfied with the efficacy of existing therapies, in this study, we investigated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afc31c0fd1be420404e73cfe9cf70ae7
https://doi.org/10.12938/bmfh.18-020
https://doi.org/10.12938/bmfh.18-020
Autor:
Yuji Ogawa, Yuichiro Eguchi, Hiroshi Ohno, Hirokazu Takahashi, Takuji Torimura, Masayoshi Kage, Takaomi Kessoku, Asako Nogami, Kento Imajo, Masato Yoneda, Haruki Usuda, Noritoshi Kobayashi, Anna Ozaki, Hideyuki Hyogo, Yoshiki Tanaka, Michihiro Iwaki, Ayako Maeda, Atsushi Nakajima, Yuki Kasai, Koichiro Wada, Shunji Nakajima, Takumi Kawaguchi, Shinichi Aishima, Yoshio Sumida, Satoru Saito, Yasushi Honda, Miwa Kawanaka, Takashi Kobayashi
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(8)
BACKGROUND AND AIM Gut microbiota composition is associated with the pathogenesis of non-alcoholic fatty liver disease. However, the association between gut microbiota composition and non-alcoholic fatty liver disease in non-obese patients remains un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f4f84928438f50a80bbd0d36385a124
https://pubmed.ncbi.nlm.nih.gov/33709477
https://pubmed.ncbi.nlm.nih.gov/33709477
Autor:
Masahide Hamaguchi, Saori Majima, Hiroshi Ohno, Takafumi Senmaru, Fumie Takewaki, Shizuo Kajiyama, Shunji Nakajima, Naoko Nakanishi, Hiroshi Okada, Hanako Nakajima, Masahiro Yamazaki, Michiaki Fukui, Yousuke Oikawa, Yoshitaka Hashimoto, Emi Ushigome, Yoshiki Tanaka
Publikováno v:
Life
Volume 10
Issue 9
Life, Vol 10, Iss 195, p 195 (2020)
Volume 10
Issue 9
Life, Vol 10, Iss 195, p 195 (2020)
Metformin is reported to affect human gut microbiota
however, the nature of this association in Japanese patients with type 2 diabetes mellitus (T2DM) is unknown. We enrolled 31 patients with T2DM who took metformin for the first time in this st
however, the nature of this association in Japanese patients with type 2 diabetes mellitus (T2DM) is unknown. We enrolled 31 patients with T2DM who took metformin for the first time in this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae00511b514656c67199a76143a937d
https://pubmed.ncbi.nlm.nih.gov/32932871
https://pubmed.ncbi.nlm.nih.gov/32932871